- Home
- FWONK vs PODD Comparison
FWONK vs PODD Comparison
Compare FWONK & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FWONK | PODD |
|---|---|---|
| Founded | 1950 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.9B | 22.1B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | FWONK | PODD |
|---|---|---|
| Price | $92.26 | $304.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 19 |
| Target Price | $110.78 | ★ $359.00 |
| AVG Volume (30 Days) | ★ 1.5M | 765.6K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.84 | ★ 3.45 |
| Revenue | ★ $4,040,000,000.00 | $2,521,800,000.00 |
| Revenue This Year | $24.25 | $32.55 |
| Revenue Next Year | $10.22 | $20.39 |
| P/E Ratio | $110.31 | ★ $88.24 |
| Revenue Growth | 8.72 | ★ 27.11 |
| 52 Week Low | $75.26 | $230.05 |
| 52 Week High | $109.36 | $354.88 |
Technical Indicators
Market Signals| Indicator | FWONK | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 40.94 |
| Support Level | $91.65 | $303.20 |
| Resistance Level | $96.62 | $317.34 |
| Average True Range (ATR) | 2.17 | 13.12 |
| MACD | -0.28 | -2.82 |
| Stochastic Oscillator | 7.15 | 3.14 |
Price Performance
Historical ComparisonAbout FWONK Liberty Media Corporation Series C Liberty Formula One
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. The company derives its maximum revenue from United Kingdom.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.